Tesamorelin
GHRH Analogue
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification. It stimulates pituitary somatotroph cells to produce and release growth hormone through the GHRH receptor.
- GHRH Receptor Agonism
- GH Axis Stimulation
- Pituitary Activity
- Somatotroph Cells
Quantified findings reported in the literature
Published, peer-reviewed studies
Metabolic effects of a growth hormone-releasing factor in patients with HIV
Randomized controlled trial documenting tesamorelin's effects on GH axis stimulation and metabolic parameters.
View source on PubMed/DOI ↗Effects of tesamorelin on body composition and metabolic parameters
View source on PubMed/DOI ↗
Third-party analytical reports
Certificates of Analysis from independent laboratories for products supplied by Stemcode. Reported values describe the analysed material; they are reported as documented and are distinct from the published literature above.
- Net content
- 10.9 mg
- Lot
- SP26-TEV10
- COA #
- COA-2026-9149583
- Report date
- 07/17/2026
- Purity (HPLC)
- 96.184%
- Net content
- 2.10 mg/mL
- Lot
- SP26-TEN30
- COA #
- 2604100415
- Report date
- 04/12/2026
Stemcode supplies Tesamorelin as a research-grade compound for laboratory research use only — not for human or animal consumption.
View the research-grade product →